Remove 2023 Remove Medical science Remove Safety Remove Sales
article thumbnail

It’s Time We Got the Most Out of Medical Affairs Data

PM360

Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact. October 2023. EPG Health.

Medical 52
article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

Casey Cronin Life sciences marketers have a unique opportunity to connect with target audiences on an individual level and foster brand safety through AI advancement. Will Big Tech’s moves within healthcare force the industry to change how it operates? Here are the best responses.

article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. This trial is anticipated to begin in the second half of 2023.